Dopamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 11/06/2017. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-7809-24
- Dosage Form
- Injection
- Presentation
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)
- Initial Posting
- 11/06/2017
- Revised Date
Reason
Other